Eli Lilly
LLY
LLY
3,885 hedge funds and large institutions have $609B invested in Eli Lilly in 2025 Q2 according to their latest regulatory filings, with 217 funds opening new positions, 1,761 increasing their positions, 1,444 reducing their positions, and 172 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
4.42% less ownership
Funds ownership: 86.95% → 82.54% (-4.4%)
10% less capital invested
Capital invested by funds: $679B → $609B (-$70.2B)
27% less funds holding in top 10
Funds holding in top 10: 394 → 288 (-106)
Holders
3,885
Holding in Top 10
288
Calls
$14.1B
Puts
$10.7B
Top Buyers
| 1 | +$3.9B | |
| 2 | +$999M | |
| 3 | +$922M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$853M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$708M |
Top Sellers
| 1 | -$39B | |
| 2 | -$2.21B | |
| 3 | -$2.05B | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.78B |
| 5 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$1.21B |
